The collaboration will focus on development of an approach that combines CMED’s Timaeus data management platform with Tessella’s existing Fates adaptive trial execution system.
Tom Parke, head of clinical technologies at Tessella, said: “With Timaeus, organisations have the ability to acquire, manage and report data in near real-time. This is particularly important for adaptive trials because it minimises the delay in the availability of response data and therefore adaptation of the trial.”
Richard Young, Director of Business Development at CMED said: “Tessella and Cmed have been collaborating for some time… entering into a partnership this will reinforce our capabilities, and provide unparalleled solutions for adaptive designs.”
